CONMED
In Howard Marks's portfolio · Oaktree Capital Management
Ticker CNMD.CV
Still in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Add 48% | 53,645,000 | 0.7% |
| Q1 2026 | Reduce 10% | 36,189,000 | 0.5% |
| Q4 2025 | No change | 40,324,000 | 0.6% |
| Q3 2025 | Add 46% | 40,513,000 | 0.6% |
| Q2 2025 | Add 59% | 27,705,000 | 0.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.